Target intelligence / Profile preview

Plasmodium falciparum mitochondrial inner membrane

Molecular classification
Other (organelle membrane), Electron transport chain (ETC) component, Metabolic complex membrane
01

Overview

The **Plasmodium falciparum mitochondrial inner membrane** is an essential, highly specialized structure within the single mitochondrion of the malaria parasite *P. falciparum*, housing the parasite’s entire electron transport chain (ETC) and associated metabolic enzymes critical for ATP synthesis and pyrimidine biosynthesis[7][10]. Unlike mammalian mitochondria, it contains unique ETC components and membrane-associated proteins, including the druggable cytochrome bc1 complex (complex III)[6][10] and enzymes absent in humans such as malate:quinone oxidoreductase (PfMQO)[3]. The membrane’s composition and ultrastructure change throughout the parasite's lifecycle to support various metabolic demands[1][7]. It is validated as a target for several antimalarial drugs, notably atovaquone and proguanil, which inhibit electron transport and mitochondrial function, leading to parasite death[2][5][9][10]. The term as given—"Plasmodium falciparum mitochondrial membrane"—is imprecise: it refers to an organellar membrane and not a single molecular entity, making it "incorrect" as a molecular target. Specific validated targets on this membrane include complex III (cytochrome bc1 complex), PfMQO, and other ETC proteins, not the membrane as a whole[3][6][10].

Other names
Plasmodium falciparum mitochondrion inner membraneP. falciparum mitochondrial membrane
02

Mechanism of action

Inhibition of complex III (cytochrome bc1 complex), disrupting electron transport and ATP generation[6][10] Reduction of mitochondrial membrane potential, especially when combining inhibitors[2][5]

03

Biological functions

ATP synthesisElectron transportPyrimidine biosynthesisMetabolic homeostasis
04

Disease associations

Infection (malaria)
05

Safety considerations

Potential for off-target mitochondrial effects in host if inhibitors are insufficiently selective[2][3][6]Drug resistance can rapidly arise, limiting therapeutic window[9]
06

Interacting drugs

Atovaquone

3 more in the full profile.

Beyond the preview

Go deeper on Plasmodium falciparum mitochondrial inner membrane.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Plasmodium falciparum mitochondrial inner membrane.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call